Nanotechnology Now - Press Release: Nanomedicine: Nanotechnology, Biology and Medicine Accepted for Coverage in MEDLINE

Home > Press > Nanomedicine: Nanotechnology, Biology and Medicine Accepted for Coverage in MEDLINE

Abstract:
Elsevier (LSE: REL , NYSE: ENL), the world's leading scientific, technical
and medical publisher has announced that its journal, Nanomedicine:
Nanotechnology, Biology and Medicine has been selected for inclusion in
MEDLINE(R). Maintained by the U.S. National Library of Medicine(R), MEDLINE
(Medical Literature Analysis and Retrieval System Online) is the premier
bibliographic database containing approximately 13 million references to
journal articles in life sciences with a concentration on biomedicine.

Nanomedicine: Nanotechnology, Biology and Medicine Accepted for Coverage in MEDLINE

PHILADELPHIA, PA | Posted on February 21st, 2007

Nanomedicine: NBM Editor-in-Chief, Chiming Wei, MD, PhD, Department of
Surgery, Johns Hopkins University School of Medicine, commented, "The
entire Editorial Board and I are extremely pleased that Nanomedicine: NBM
is being added to the MEDLINE journal collection so soon after its launch
in March 2005 in recognition of its scientific merit and contribution to
the field. Inclusion in this prominent database will help investigators
throughout the world more easily locate articles published in Nanomedicine:
NBM.

Nanomedicine: Nanotechnology, Biology and Medicine
( http://www.nanomedjournal.org ), the Official Journal of the American Academy of
Nanomedicine (AANM), is an international, peer-reviewed journal published
quarterly. Nanomedicine: NBM publishes basic, clinical and engineering
research in the innovative field of nanomedicine. Article categories
include diagnostic, experimental, clinical, engineering, pharmacological
and basic nanomedicine. Nanomedicine: NBM provides the latest information
in this rapidly developing field, covering both research advancements and
clinical applications. The Journal publishes original clinical and
investigative studies, state-of-the-art papers, reports on new equipment
and techniques, review articles and more.

Nanomedicine, an offshoot of nanotechnology, refers to highly specific
medical intervention at the molecular scale for curing disease or repairing
damaged tissues, such as bone, muscle or nerve. A nanometer is
one-billionth of a meter, too small to be seen with a conventional lab
microscope. It is at this size scale - about 100 nanometers or less - that
biological molecules and structures inside living cells operate.

The National Library of Medicine MEDLINE selection process is managed
by an advisory committee, the Literature Selection Technical Review
Committee, composed of authorities knowledgeable in the field of
biomedicine, such as physicians, researchers, educators, editors, health
science librarians and historians, to review and recommend the journal
titles NLM should index. With inclusion in MEDLINE, citations, abstracts
and indexing terms for articles published in Nanomedicine: NBM will be
available online in the U.S. and throughout the world back to Volume
1/Issue 1. MEDLINE is searchable for free using PubMed at
http://pubmed.gov .

Elsevier, a world-leading medical and scientific publisher, brings the
full support of its global organization to the journal. It is recognized
for its numerous long-standing and successful society-publishing
partnerships, as well as excellence in all aspects of the publishing
process. ScienceDirect ( http://www.sciencedirect.com ), Elsevier's world-class
electronic platform with over 16 million users, provides online access to
the full text of Nanomedicine: NBM to institutional subscribers. Members of
the affiliated society and individual subscribers are able to access the
journal via http://www.nanomedjournal.org .

####

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in over
70 offices worldwide publish more than 2,000 journals and 1,900 new books
per year, in addition to offering a suite of innovative electronic
products, such as ScienceDirect ( http://www.sciencedirect.com/ ), MD Consult
( http://www.mdconsult.com/ ), Scopus ( http://www.info.scopus.com/ ),
bibliographic databases and online reference works.

Elsevier ( http://www.elsevier.com/ ) is a global business headquartered
in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part
of Reed Elsevier Group plc ( http://www.reedelsevier.com/ ), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).

ABOUT THE AMERICAN ACADEMY OF NANOMEDICINE

The American Academy of Nanomedicine ( http://www.aananomed.org ) is a forum to exchange ideas, communicate new findings and encourage collaboration among
the diverse disciplines represented in Nanomedicine. Membership in AANM
includes a subscription to Nanomedicine: Nanotechnology, Biology, and
Medicine.